Company Description
Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.
It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions.
The Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in various therapeutic areas, such as screenings for hereditary diseases, pharmacogenetics, and oncology related applications.
The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries.
This segment also provides testing and laboratory services primarily to the dental industry. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis and peptide synthesis solutions.
This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enable customers to automate chemical synthesis of peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research.
The Calibration Solutions segment designs, manufactures, and markets quality control products to measure or calibrate temperature, pressure, pH, and humidity for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory environments.
This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems.
The company was incorporated in 1982
| Country | United States |
| Founded | 1982 |
| Industry | Scientific & Technical Instruments |
| Sector | Technology |
| Employees | 698 |
| CEO | Gary M. Owens |
Contact Details
Address: 12100 W 6th Ave Lakewood, Colorado 80228 United States | |
| Phone | (303) 987-8000 |
| Website | mesalabs.com |
Stock Details
| Ticker Symbol | MLAB |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0000724004 |
| CUSIP Number | 59064R109 |
| ISIN Number | US59064R1095 |
| Employer ID | 84-0872291 |
| SIC Code | 3823 |
Key Executives
| Name | Position |
|---|---|
| Gary M. Owens | Chief Executive Officer, President and Director |
| John V. Sakys | Vice President, Chief Financial Officer and Chief Accounting Officer |
| Brian David Archbold | Senior Vice President of Continuous Improvement |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 8, 2024 | 8-K | Current Report |
| Apr 2, 2024 | 8-K | Current Report |
| Feb 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 5, 2024 | 10-Q | Quarterly Report |
| Feb 5, 2024 | 8-K | Current Report |
| Jan 23, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jan 22, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jan 8, 2024 | 8-K | Current Report |
| Jan 5, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Dec 15, 2023 | 144 | Filing |